COMPASS THERAPEUTICS, INC. (CMPX) Current Ratio
- Current ratio · latest quarter: Value 11.22×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 11.22× | Current assets / current liabilities. $180.89M ÷ $16.13M ≈ 11.22× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 180.89M USD | Assets, Current |
| Current obligations | 16.13M USD | Liabilities, Current |
| Cash and equivalents | 35.45M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 144.43M USD | Marketable Securities, Current |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 2.91M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $180.89M | $16.13M | $35.45M | $144.43M | (m) | (m) | $2.91M | (m) | 11.22× |
| 2026-03-31 | $195.69M | $10.28M | $55.17M | $139.52M | (m) | (m) | $906.00K | (m) | 19.04× |
| 2025-12-31 | $209.82M | $13.97M | $30.64M | $178.26M | (m) | (m) | $1.58M | (m) | 15.02× |
| 2025-09-30 | $221.12M | $12.41M | $46.21M | $173.68M | (m) | (m) | $3.10M | (m) | 17.82× |
| 2025-06-30 | $106.19M | $13.86M | $22.86M | $78.09M | (m) | (m) | $2.60M | (m) | 7.66× |
| 2025-03-31 | $124.14M | $14.90M | $41.05M | $71.59M | (m) | (m) | $1.58M | (m) | 8.33× |
| 2024-12-31 | $132.75M | $8.87M | $43.48M | $83.24M | (m) | (m) | $2.25M | (m) | 14.96× |
| 2024-09-30 | $141.14M | $4.43M | $36.80M | $98.60M | (m) | (m) | $960.00K | (m) | 31.84× |
| 2024-06-30 | $153.55M | $9.51M | $19.40M | $126.82M | (m) | (m) | $1.19M | (m) | 16.15× |
| 2024-03-31 | $158.61M | $3.89M | $23.67M | $132.58M | (m) | (m) | $854.00K | (m) | 40.74× |
| 2023-12-31 | $153.88M | $7.80M | $24.23M | $128.23M | (m) | (m) | $4.09M | (m) | 19.73× |
| 2023-09-30 | $166.58M | $9.12M | $30.43M | $133.28M | (m) | (m) | $2.31M | (m) | 18.26× |
| 2023-06-30 | $175.27M | $9.70M | $19.28M | $149.47M | (m) | (m) | $724.00K | (m) | 18.07× |
| 2023-03-31 | $183.60M | $11.19M | $27.03M | $148.14M | (m) | (m) | $1.13M | (m) | 16.41× |
| 2022-12-31 | $194.79M | $16.17M | $34.95M | $151.66M | (m) | (m) | $3.38M | (m) | 12.05× |
| 2022-09-30 | $122.55M | $9.58M | $16.48M | $104.12M | (m) | (m) | $2.76M | (m) | 12.80× |
| 2022-06-30 | $134.54M | $10.88M | $26.24M | $105.78M | (m) | (m) | $6.53M | (m) | 12.36× |
| 2022-03-31 | $140.28M | $9.33M | $136.38M | (m) | (m) | (m) | $257.00K | (m) | 15.03× |
| 2021-12-31 | $147.10M | $10.63M | $144.51M | $0.00 | (m) | (m) | $867.00K | (m) | 13.84× |
| 2021-09-30 | $28.57M | $7.68M | $25.51M | (m) | (m) | (m) | $868.00K | $3.74M | 3.72× |
| 2021-06-30 | $34.53M | $8.39M | $31.21M | (m) | (m) | (m) | $559.00K | $5.61M | 4.11× |
| 2021-03-31 | $41.65M | $10.85M | $39.70M | (m) | (m) | (m) | $1.06M | $7.47M | 3.84× |
| 2020-12-31 | $50.20M | $10.10M | $47.08M | (m) | (m) | (m) | $1.06M | $7.47M | 4.97× |
| 2020-09-30 | $57.83M | $9.67M | $55.52M | (m) | (m) | (m) | $854.00K | $7.46M | 5.98× |
| 2020-06-30 | $67.29M | $11.61M | $65.37M | (m) | (m) | (m) | $1.58M | $7.45M | 5.80× |
| 2020-03-31 | $3.75K | $111.82K | $3.75K | (m) | (m) | (m) | (m) | (m) | 0.03× |
| 2019-12-31 | $26.24M | $9.82M | $25.30M | (m) | (m) | (m) | $629.00K | $5.58M | 2.67× |
| 2019-09-30 | $882.00 | $91.34K | $882.00 | (m) | (m) | (m) | (m) | (m) | 0.01× |
| 2019-06-30 | $4.87K | $86.92K | $4.87K | (m) | (m) | (m) | (m) | (m) | 0.06× |
| 2019-03-31 | $4.87K | $75.45K | $4.87K | (m) | (m) | (m) | (m) | (m) | 0.06× |
| 2018-12-31 | $4.68K | $66.40K | $4.68K | (m) | (m) | (m) | (m) | (m) | 0.07× |
| 2018-09-30 | $2.45K | $54.03K | $2.45K | (m) | (m) | (m) | (m) | (m) | 0.05× |
| 2018-06-30 | $7.23K | $50.26K | $7.23K | (m) | (m) | (m) | (m) | (m) | 0.14× |
| 2018-03-31 | $25.00 | $34.58K | (m) | (m) | (m) | (m) | (m) | (m) | 0.00× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |